Wei Zhang

22PUBLICATIONS
65CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 15, 2026
Liposomal mitoxantrone plus tislelizumab in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma: a phase 1b/2 trial.

|Apr 24, 2026
UNC13D in Familial Hemophagocytic Lymphohistiocytosis and Beyond: Functional Mechanisms, Genetic Variants, Multisystem Disease Spectrum and Clinical Implications.

|Feb 11, 2026
Clonal haematopoiesis in T-follicular helper cell lymphoma: A prognostic biomarker and early event in lymphoma evolution.

Chong Wei, Yan Zhang, Danqing Zhao

|Jun 24, 2025
Germline defects of familial haemophagocytic lymphohistiocytosis-Related genes may represent a predisposing factor for mature T- and natural killer-cell lymphoma.

Chong Wei, Yan Zhang, Danqing Zhao

|Sep 27, 2024
Time to lymphoma treatment within 24 months in 'watch and wait' follicular lymphoma is associated with inferior outcomes: A multicentre analysis.

Jing Liu, Fenghua Gao, Tingting Zhang

|Jul 08, 2024
A retrospective study of prognostic factors and treatment outcome in advanced-stage Mycosis Fungoides and Sezary Syndrome.

Zhuo-Fan Xu, Hongyun Chen, Yuehua Liu

Pageof 4

Frequent Collaborators

8 joint publications

DaoBin Zhou

7 joint publications

Yan Zhang

5 joint publications

Wei Chong

3 joint publications

Xiao Zhang